
Brainsway Ltd. BWAY
$ 13.06
-3.19%
Annual report 2024
added 03-21-2026
Brainsway Ltd. P/CF Ratio 2011-2026 | BWAY
Annual P/CF Ratio Brainsway Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 271 | -58.9 | -13.8 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 271 | -58.9 | 66.2 |
P/CF Ratio of other stocks in the Diagnostics research industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Bioventus
BVS
|
8.14 | $ 9.25 | -0.11 % | $ 616 M | ||
|
Biodesix
BDSX
|
-1.89 | $ 14.56 | -0.27 % | $ 1.89 B | ||
|
DarioHealth Corp.
DRIO
|
-1.27 | $ 8.45 | - | $ 33.7 M | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
39.7 | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.541 | - | - | $ 9.42 M | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
IDEXX Laboratories
IDXX
|
43.3 | $ 566.57 | -1.17 % | $ 45.6 B | ||
|
Medpace Holdings
MEDP
|
18.2 | $ 462.67 | -0.84 % | $ 13.3 B | ||
|
Illumina
ILMN
|
19.6 | $ 121.35 | -2.45 % | $ 19.3 B | ||
|
Trinity Biotech plc
TRIB
|
9.03 | $ 0.62 | 1.06 % | $ 61.9 M | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
Co-Diagnostics
CODX
|
-1.58 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
OPKO Health
OPK
|
-6.62 | $ 1.14 | -2.44 % | $ 791 M | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
National Research Corporation
NRC
|
11.9 | $ 16.93 | -2.48 % | $ 379 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
VolitionRx Limited
VNRX
|
-2.12 | $ 0.19 | -3.63 % | $ 18.3 M | ||
|
Charles River Laboratories International
CRL
|
10.4 | $ 160.77 | -2.64 % | $ 7.97 B | ||
|
Organovo Holdings
ONVO
|
-0.328 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
-1.87 | - | -16.95 % | $ 1.54 M | ||
|
Waters Corporation
WAT
|
30.1 | $ 295.27 | -1.76 % | $ 17.6 B | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
ENDRA Life Sciences
NDRA
|
-0.297 | $ 4.79 | 6.32 % | $ 2.57 M | ||
|
PerkinElmer
PKI
|
22.5 | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
-1.04 | - | - | $ 21.2 M | ||
|
Exagen
XGN
|
-5.14 | $ 2.71 | -2.87 % | $ 58.4 M | ||
|
Interpace Biosciences
IDXG
|
0.888 | $ 1.73 | 2.37 % | $ 7.59 M | ||
|
Soleno Therapeutics
SLNO
|
44.5 | $ 31.12 | -2.23 % | $ 1.58 B | ||
|
RadNet
RDNT
|
18.8 | $ 57.9 | -2.54 % | $ 4.35 B | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
12.6 | - | - | $ 10.6 B | ||
|
Thermo Fisher Scientific
TMO
|
25.1 | $ 482.91 | -1.22 % | $ 182 B | ||
|
Celcuity
CELC
|
-35 | $ 114.04 | -0.67 % | $ 5.33 B | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Senseonics Holdings
SENS
|
-5.93 | $ 6.53 | -0.53 % | $ 272 M | ||
|
Laboratory Corporation of America Holdings
LH
|
14.6 | $ 265.93 | -0.91 % | $ 22.1 B | ||
|
NeoGenomics
NEO
|
284 | $ 7.58 | -2.32 % | $ 971 M | ||
|
Psychemedics Corporation
PMD
|
-11.4 | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
-2.44 | $ 26.54 | -2.43 % | $ 34.4 M | ||
|
CareDx, Inc
CDNA
|
23.6 | $ 17.22 | -1.43 % | $ 918 M |